Burford Capital Limited Forecasted to Post Q3 2024 Earnings of $0.48 Per Share (NYSE:BUR)
Burford Capital Limited (NYSE:BUR – Free Report) – Equities research analysts at B. Riley decreased their Q3 2024 earnings per share estimates for Burford Capital in a note issued to investors on Tuesday, April 9th. B. Riley analyst M. Howlett now forecasts that the company will earn $0.48 per share for the quarter, down from […]
More Stories
Critical Review: i-80 Gold (IAUX) & Its Rivals
i-80 Gold (NYSE:IAUX – Get Free Report) is one of 114 publicly-traded companies in the “Gold & silver ores” industry,...
Hillman Solutions Corp (NASDAQ:HLMN) Receives $14.20 Average Target Price from Analysts
Hillman Solutions Corp (NASDAQ:HLMN – Get Free Report) has earned an average rating of “Moderate Buy” from the six ratings...
Equity Residential (NYSE:EQR) Receives Consensus Rating of “Hold” from Analysts
Equity Residential (NYSE:EQR – Get Free Report) has been assigned a consensus rating of “Hold” from the nineteen brokerages that...
Comparing NLS Pharmaceutics (NASDAQ:NLSP) and Atossa Therapeutics (NASDAQ:ATOS)
Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) and NLS Pharmaceutics (NASDAQ:NLSP – Get Free Report) are both small-cap medical companies,...
Contrasting Globalstar (GSAT) & Its Rivals
Globalstar (NYSEARCA:GSAT – Get Free Report) is one of 32 publicly-traded companies in the “Communication services, not elsewhere classified” industry,...
Head-To-Head Contrast: AIM ImmunoTech (NYSE:AIM) versus INmune Bio (NASDAQ:INMB)
INmune Bio (NASDAQ:INMB – Get Free Report) and AIM ImmunoTech (NYSE:AIM – Get Free Report) are both small-cap medical companies,...